Calcium

CHEMBL1200496 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
40.1 g/mol
LogP
Phase
4

An essential mineral critical for bone and tooth formation, muscle contraction, nerve transmission, and blood clotting. As a supplement, it is used to prevent or treat calcium deficiency, osteoporosis, and to bind phosphate in kidney disease patients. Intravenous calcium is used emergently to treat life-threatening electrolyte imbalances.

Molekularmasse

40,0800 g/mol

TPSA

0,00 Ų

Therapeutische Bereiche

Wirkmechanismus

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[Ca]

InChI

InChI=1S/Ca

Molecular Formula

Ca

HBD / HBA

- / -

Rotierbare Bindungen

0

Schwere Atome

1

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

An essential mineral critical for bone and tooth formation, muscle contraction, nerve transmission, and blood clotting. As a supplement, it is used to prevent or treat calcium deficiency, osteoporosis, and to bind phosphate in kidney disease patients. Intravenous calcium is used emergently to treat life-threatening electrolyte imbalances.

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Yes, Calcium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200496. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5460341. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.